Zepbound: First Approved Treatment for Sleep Apnea in Obese Adults
Zepbound is now the first FDA-approved medication for treating moderate-to-severe obstructive sleep apnea in adults with obesity, offering new hope for sufferers.
Zepbound is the first medicine approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity.